Recce Pharmaceuticals Finds 'Promising' Results From Nebulized RECCE 327 Pilot Study
Recce Pharmaceuticals Finds 'Promising' Results From Nebulized RECCE 327 Pilot Study
Recce Pharmaceuticals 从雾化 RECCE 327 试点研究中发现 “令人鼓舞” 的结果
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册